Celgene is now part of Bristol Myers Squibb creating a leading biopharma company positioned to help address the needs of patients with serious diseases. With effect from 1 June 2020 all new corporate giving funding requests will need to be requested via the BMS webpage – link here. If you have an existing request that is already in progress, this will be completed using the existing Celgene process and does not need to be resubmitted.

NP-IE-NA-0123
Date of Preparation: May 2020